Dendreon Corp fka DNDNQ

[rancherho]

The Journal of Clinical Investigation has a free accessible issue on Tumor Immunology at:
https://www.the-jci.org/publiTron.php?series_id=55&action=review_series
One of the articles in the Review "DC-based Cancer Vaccines" fails to even mention the Provenge clinical trials, which I thought was odd. OTOH, DNDN's presentation at the March 29th AC meeting was so devoid of any discussion of immunology factors (eg, Treg levels, CD8 T cell persistence in vivo, antigen cascade / epitope spreading, etc) that their contribution to immunology science, whether Provenge is eventually approved or not, may be considered minimal. JMHO.